العربية
Part of the Master Guide

Discover Prof. Dr. Mohammed Hutaif: Sana'a's Leading Orthopedic Surgeon & Spine Specialist – Your Path to Pain-Free Movement

Total Hip Arthroplasty (THA): Comprehensive Review of Epidemiology, Anatomy & Biomechanics

30 مارس 2026 20 min read 91 Views

Key Takeaway

Total Hip Arthroplasty (THA) is a highly successful surgical intervention relieving pain and restoring function for end-stage hip pathology, primarily osteoarthritis. It involves replacing damaged bone and cartilage with prosthetic components. Understanding its detailed epidemiology, surgical anatomy, biomechanics, and precise indications is crucial for optimal patient outcomes and functional recovery.

Introduction & Epidemiology

Total Hip Arthroplasty (THA) stands as one of the most successful surgical interventions in modern medicine, effectively alleviating pain and restoring function in patients suffering from end-stage hip pathology. First performed by Sir John Charnley in the 1960s, THA has undergone significant evolution in implant design, materials, surgical techniques, and perioperative management. The procedure's success is largely attributed to its predictable outcomes in addressing severe osteoarthritis (OA), a vascular necrosis (AVN), inflammatory arthropathies, and certain traumatic conditions affecting the hip joint.

Epidemiologically, the burden of hip OA is substantial and growing, particularly in an aging global population. The incidence of THA has steadily increased over the past several decades, with projections indicating continued growth. In the United States, over 450,000 THAs are performed annually, and this number is expected to exceed 600,000 by 2030. While OA remains the primary indication, accounting for approximately 90% of cases, other conditions such as AVN, rheumatoid arthritis, post-traumatic arthritis, and certain femoral neck fractures contribute to the remaining volume. Patients undergoing THA typically present in their sixth or seventh decade of life, although the procedure is increasingly performed in younger, more active individuals, as well as select elderly patients with significant functional limitations. The economic impact is considerable, with healthcare expenditures for THA reaching billions annually, underscoring the importance of optimizing outcomes and efficiency.

Surgical Anatomy & Biomechanics

A thorough understanding of the intricate anatomy and biomechanics of the hip joint is paramount for successful THA.

Surgical Anatomy

  • Pelvis: Key bony landmarks include the acetabulum (formed by the ilium, ischium, and pubis), anterior superior iliac spine (ASIS), posterior superior iliac spine (PSIS), ischial tuberosity, and pubic symphysis. The acetabulum's orientation (inclination and anteversion) is critical for component positioning. Neurovascular structures in proximity include the superior and inferior gluteal arteries and nerves, sciatic nerve (exiting greater sciatic notch), femoral nerve and vessels (within femoral triangle), and obturator nerve and vessels (passing through obturator foramen).
  • Proximal Femur: Comprises the femoral head (articular surface), femoral neck, greater trochanter (insertion of gluteus medius/minimus), lesser trochanter (insertion of iliopsoas), intertrochanteric line/crest, and femoral shaft. The femoral head and neck derive blood supply primarily from the medial and lateral circumflex femoral arteries.
  • Capsule and Ligaments: The hip joint is encapsulated by a strong fibrous capsule, reinforced by the iliofemoral, pubofemoral, and ischiofemoral ligaments. These ligaments contribute significantly to hip stability and are selectively released or protected based on the chosen surgical approach.
  • Musculature:
    • Gluteal Muscles: Gluteus maximus (hip extension, external rotation), gluteus medius and minimus (hip abduction, internal rotation), critical for gait stability.
    • Short External Rotators: Piriformis, superior and inferior gemelli, obturator internus and externus, quadratus femoris. These are often released or divided in posterior approaches.
    • Iliopsoas: Primary hip flexor, inserts on the lesser trochanter.
    • Adductors: Pectineus, adductor longus, brevis, magnus, gracilis.
    • Vastus Lateralis: Originates from the greater trochanter and lateral linea aspera, forms part of the quadriceps.

Biomechanics

  • Joint Loading: The hip joint is subjected to significant loads, often 3-5 times body weight during single-leg stance and up to 7-8 times body weight during activities like running. These forces are distributed across the articular surfaces.
  • Abductor Mechanism: The gluteus medius and minimus generate an abductor moment that counteracts the adductor moment produced by body weight acting through the hip's center of rotation. A sufficient lever arm for the abductors is crucial for minimizing joint reaction forces and preventing a Trendelenburg gait.
  • Center of Rotation (COR): Proper restoration of the hip's anatomical COR is essential for optimizing joint biomechanics, minimizing stresses on the implant and periprosthetic bone, and ensuring stable gait. Medialization or lateralization of the COR can significantly alter muscle efficiency and joint loading.
  • Offset and Leg Length:
    • Femoral Offset: The horizontal distance from the center of rotation to the mechanical axis of the femur. Restoration of appropriate femoral offset is crucial for abductor muscle tension and strength.
    • Leg Length: Accurate restoration of leg length is vital to prevent gait abnormalities, pelvic obliquity, and nerve stretch injuries. Discrepancies can lead to functional impairment and patient dissatisfaction.
  • Implant Mechanics: Implant design considerations include material properties, fixation methods (cemented vs. uncemented), bearing surfaces (e.g., metal-on-polyethylene, ceramic-on-polyethylene, ceramic-on-ceramic), and component geometry. These choices influence implant longevity, wear characteristics, and risk of aseptic loosening.

Indications & Contraindications

The decision for THA is primarily clinical, guided by patient symptoms, functional limitations, and radiographic findings.

Indications for THA (Operative)

  • End-stage Degenerative Arthritis:
    • Primary osteoarthritis (most common indication).
    • Secondary osteoarthritis due to developmental dysplasia of the hip (DDH), slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes disease, or prior trauma.
    • Pain, stiffness, and functional impairment refractory to comprehensive non-operative management (e.g., activity modification, analgesics, physical therapy, intra-articular injections).
  • Avascular Necrosis (AVN) of the Femoral Head: Advanced stages (e.g., Ficat IV or large collapse) often necessitate THA.
  • Inflammatory Arthropathies: Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, with symptomatic joint destruction.
  • Post-Traumatic Arthritis: Following acetabular or femoral head fractures that lead to irreversible joint damage.
  • Certain Femoral Neck Fractures: Displaced intracapsular femoral neck fractures in physiologically active and healthy elderly patients, where hemiarthroplasty might be less desirable due to potential for acetabular erosion or limited functional recovery.
  • Failed Prior Surgery: Such as failed osteotomy, hemiarthroplasty (conversion THA), or hip fusion with intractable pain.
  • Bone Tumors: Resection of tumors involving the proximal femur or acetabulum requiring reconstruction.

Contraindications for THA (Absolute & Relative)

  • Absolute Contraindications:
    • Active Systemic or Local Infection: Especially periarticular infection, which carries a high risk of periprosthetic joint infection (PJI).
    • Sepsis: Any active systemic infection.
    • Rapidly Progressive Neurological Disease: Conditions leading to neuromuscular instability or inability to protect the joint (e.g., advanced Parkinson's disease, amyotrophic lateral sclerosis) may preclude a successful outcome.
    • Skeletal Immaturity: Unless for specific tumor resections.
    • Charcot Arthropathy: High risk of instability and loosening.
  • Relative Contraindications:
    • Severe Medical Comorbidities: Uncontrolled cardiac disease, pulmonary disease, renal failure, or coagulopathies that significantly increase surgical and anesthetic risks. Medical optimization is crucial.
    • Morbid Obesity (BMI > 40-50 kg/m²): Increased risk of PJI, dislocation, thromboembolism, and technical challenges. Weight loss prior to surgery is often recommended.
    • Active Vascular Disease: Severe peripheral vascular disease in the affected limb, potentially compromising wound healing.
    • Lack of Patient Compliance or Motivation: Essential for adherence to rehabilitation protocols and precautions.
    • Unrealistic Patient Expectations: Poor understanding of potential outcomes or limitations.
    • Extensive Soft Tissue Defect or Insufficiency: Limits wound closure and increases infection risk.

TABLE: Operative vs. Non-Operative Indications

Indication Category Non-Operative Management (Initial/Preferred) Operative Management (THA Indication)
Pain/Function Mild to moderate pain, manageable with NSAIDs, activity modification, PT, injections; minimal functional limitation. Severe, intractable pain at rest or with activity; significant functional limitations (ADLs, ambulation); nocturnal pain; failure of comprehensive non-operative measures.
Radiographic Findings Mild to moderate joint space narrowing, early osteophytes, minimal subchondral sclerosis. End-stage arthritis: severe joint space narrowing, subchondral cyst formation, large osteophytes, subchondral sclerosis, joint deformity, severe AVN with collapse.
Etiology Early OA, mild AVN without collapse, non-displaced/stable fractures. Advanced OA, AVN with collapse (Ficat III/IV), inflammatory arthropathy with joint destruction, certain displaced femoral neck fractures in active individuals.
Patient Factors High surgical risk due to uncontrolled comorbidities; patient preference for conservative treatment; insufficient rehabilitation motivation. Physiologically optimized patient; motivation for rehabilitation; realistic expectations; adequate social support.

Pre-Operative Planning & Patient Positioning

Meticulous pre-operative planning and appropriate patient positioning are critical for minimizing complications and achieving optimal surgical outcomes in THA.

Pre-Operative Planning

  1. Patient Evaluation & Optimization:
    • Medical Clearance: Comprehensive assessment by the primary care physician or appropriate specialists (e.g., cardiology, pulmonology) to identify and optimize comorbidities (e.g., diabetes, hypertension, anemia).
    • Anesthetic Evaluation: Assessment of airway, cardiac risk, and suitability for regional versus general anesthesia.
    • Informed Consent: Detailed discussion of risks (e.g., infection, dislocation, nerve injury, leg length discrepancy, DVT/PE), benefits, alternatives, and expected recovery.
    • DVT Prophylaxis: Individualized risk assessment and plan for chemoprophylaxis (e.g., aspirin, LMWH, DOACs) and mechanical prophylaxis.
    • Surgical Site Infection (SSI) Prevention: Pre-operative showering with antiseptic soap, pre-operative antibiotics (typically cefazolin within 60 minutes of incision), screening for MRSA/MSSA and decolonization if positive.
    • Nutritional Status: Optimization, especially in malnourished patients.
  2. Imaging:
    • Standard Radiographs: Anteroposterior (AP) pelvis view with both hips (calibrated for templating), lateral view of the affected hip, and an AP view of the proximal femur. These are essential for assessing joint destruction, bone stock, deformity, and templating.
    • Advanced Imaging (Selected Cases): CT scan for complex acetabular deformities (e.g., DDH, protrusio acetabuli), prior failed surgery, or for 3D templating/patient-specific instrumentation. MRI for occult infection or specific soft tissue concerns.
  3. Implant Selection & Templating:
    • Bearing Surfaces: Choice between metal-on-polyethylene (MoP), ceramic-on-polyethylene (CoP), and ceramic-on-ceramic (CoC) based on patient age, activity level, and surgeon preference. Dual mobility constructs offer enhanced stability, particularly in high-risk patients.
    • Fixation: Cemented (typically for older patients with poor bone stock), uncemented (younger, active patients with good bone quality), or hybrid (e.g., uncemented acetabulum, cemented femur).
    • Stem Type: Standard, collared, short stems, or custom stems for complex anatomies.
    • Head Size: Larger femoral heads (e.g., >36mm) are associated with reduced dislocation rates but may have increased wear or impingement risks depending on bearing.
    • Templating: Digital or manual templating is performed on radiographs to estimate appropriate component sizes (acetabular shell, liner, femoral stem, head), predict leg length changes, and restore femoral offset. This guides intraoperative decision-making.

Patient Positioning

The choice of patient position depends on the planned surgical approach. Irrespective of the position, meticulous care must be taken to prevent iatrogenic nerve compression, pressure sores, and vascular compromise.

  1. Lateral Decubitus Position:
    • Used for: Posterior and Anterolateral approaches.
    • Setup: Patient is placed on their unaffected side. The ipsilateral arm is often supported on an armrest, and the contralateral arm positioned to avoid brachial plexus compression. The pelvis is stabilized with sacral and pubic posts/supports. Pillows are placed between the knees and ankles. The surgical leg is draped free.
    • Considerations: Ensures adequate exposure of the posterior and lateral hip. Requires careful padding of bony prominences (e.g., fibular head, greater trochanter of the dependent hip) and prevention of excessive pressure on the dependent arm/axilla.
  2. Supine Position:
    • Used for: Direct Anterior Approach (DAA) and Modified Anterolateral approaches.
    • Setup: Patient is flat on their back. A bump or bolster may be placed under the ipsilateral hip for some modified anterior approaches. For DAA, a specialized traction table (e.g., Hana table) or a standard table with specific leg positioning (e.g., "figure-4" position) may be used to facilitate femoral exposure.
    • Considerations: Allows for intraoperative fluoroscopy for component positioning and leg length assessment, especially with DAA. Requires careful attention to foot position to prevent internal/external rotation contractures, and padding of the sacrum, heels, and elbows.

Detailed Surgical Approach / Technique

The choice of surgical approach significantly influences muscle sparing, dislocation risk, and rehabilitation protocols. The main approaches are posterior, anterolateral, and direct anterior. We will detail the Posterior Approach , as it is widely used and provides comprehensive anatomical exposure.

Posterior Approach to the Hip

The posterior approach (Kocher-Langenbeck or modified) is traditionally one of the most common approaches due to excellent exposure of the acetabulum and femur, and versatility for revision surgery.

  1. Incision:
    • Skin Incision: A curvilinear or straight incision is made, centered over the greater trochanter. It typically extends from 5-7 cm superior and posterior to the greater trochanter, distally along the posterior shaft of the femur for about 10-15 cm.
    • Subcutaneous Dissection: The incision is deepened through the subcutaneous fat to the fascia lata.
  2. Fascial Incision:
    • The fascia lata is incised longitudinally in line with the skin incision, posterior to the greater trochanter. This exposes the gluteus maximus muscle.
  3. Muscle Dissection and Internervous Planes:
    • The gluteus maximus is split longitudinally along its fibers, blunt dissection usually suffices. This is an intermuscular approach within the gluteus maximus, sparing the superior gluteal nerve which innervates the gluteus medius and minimus.
    • Retraction of the gluteus maximus reveals the underlying short external rotators (piriformis, superior and inferior gemelli, obturator internus, quadratus femoris) and the posterior capsule. The sciatic nerve lies deep to these muscles, medial to the ischial tuberosity, and is extremely vulnerable; meticulous retraction and protection are paramount.
  4. Capsular Incision and Short External Rotator Release:
    • The short external rotators (typically piriformis, superior and inferior gemelli, and obturator internus) are identified and sharply released from their insertions on the greater trochanter. These are often tagged with sutures for later repair.
    • The posterior capsule is then incised, typically in a T-shape or linear fashion, to expose the femoral head. A capsulectomy may be performed, but capsular repair is generally preferred to enhance stability.
  5. Hip Dislocation:
    • The hip is flexed, adducted, and internally rotated to dislocate the femoral head posteriorly. Care is taken to protect the sciatic nerve during this maneuver.
  6. Femoral Osteotomy:
    • The femoral head is resected using an oscillating saw. The level of osteotomy is determined pre-operatively (templating) and intraoperatively to match the prosthetic neck cut and restore leg length and offset.
  7. Acetabular Preparation:
    • The acetabulum is exposed by retracting the femur anteriorly.
    • The labrum and any osteophytes are debrided.
    • Serial reaming of the acetabulum is performed, typically starting with a reamer 2-4mm smaller than the templated component, progressively increasing the size until healthy subchondral bone is reached and bleeding from the cancellous bone is observed. Reaming should be performed symmetrically to achieve proper component inclination (40-45 degrees) and anteversion (15-20 degrees).
    • Trial acetabular components are inserted to assess fit, stability, and range of motion.
    • The definitive acetabular shell (uncemented) is then impacted into place. Screws may be inserted for additional fixation if primary stability is not optimal. A polyethylene or ceramic liner is then locked into the shell.
  8. Femoral Preparation:
    • The femoral canal is prepared by progressive reaming and broaching, following the natural curvature of the femur. The broaches incrementally create the shape and size of the femoral stem's proximal portion.
    • Trial femoral components (stem and head) are inserted to assess fit, stability, leg length, and offset. This is the critical stage for final adjustments.
  9. Reduction & Final Assessment:
    • The hip is reduced.
    • Stability: The hip's stability is assessed through a full range of motion, ensuring no impingement or dislocation in flexion, adduction, internal rotation (FAIR maneuver), or extension, abduction, external rotation.
    • Leg Length and Offset: These are meticulously checked clinically (pelvic tilt, ASIS to medial malleolus measurements) and, if utilized, fluoroscopically. Adjustments are made by altering femoral head length (neck options) or stem position.
  10. Closure:
    • The short external rotators and posterior capsule are repaired to the greater trochanter using strong, non-absorbable sutures to enhance posterior stability.
    • The fascia lata is repaired.
    • Subcutaneous tissues are closed in layers.
    • Skin closure using staples or sutures. A drain may be inserted if significant bleeding is anticipated.

Complications & Management

Despite high success rates, THA is associated with potential complications, which can significantly impact patient outcomes. Vigilant prevention, early recognition, and appropriate management are crucial.

General Complications

  • Thromboembolic Disease (DVT/PE): Deep vein thrombosis (DVT) and pulmonary embolism (PE) are serious risks.
    • Incidence: DVT 0.5-5% with prophylaxis; PE 0.1-1%.
    • Management: Pre-operative risk assessment, appropriate chemoprophylaxis (aspirin, LMWH, DOACs) and mechanical prophylaxis (compression stockings, SCDs). Treatment involves anticoagulation.
  • Surgical Site Infection (SSI): Can range from superficial wound infection to deep periprosthetic joint infection (PJI).
    • Incidence: Superficial 1-3%; deep PJI 0.5-2%.
    • Management: Pre-operative antibiotics, skin preparation, sterile technique, glycemic control. For superficial infections, wound care and oral antibiotics. For deep PJI, surgical debridement and retention of implant (DAIR) in acute cases, or one-/two-stage revision arthroplasty for chronic infections.
  • Neurovascular Injury:
    • Incidence: Neuropraxia (e.g., sciatic nerve, femoral nerve) 0.1-1%; vascular injury <0.1%.
    • Management: Careful surgical dissection, avoidance of excessive traction/retraction, meticulous hemostasis. Early recognition, neurolysis, or vascular repair. Most neuropraxias are temporary.
  • Fracture: Intraoperative periprosthetic fracture.
    • Incidence: 0.3-5% (higher in revisions or specific anatomies).
    • Management: Often managed with cerclage wires, plates, or revision to a longer, more stable stem, depending on location and stability.

THA-Specific Complications

  • Dislocation:
    • Incidence: 1-5% (higher in revisions, certain approaches like posterior, or patients with poor abductor function).
    • Management: Closed reduction under anesthesia is the initial treatment. Recurrent dislocations may require bracing, re-orientation of components, or revision arthroplasty with larger heads, constrained liners, or dual-mobility components.
  • Periprosthetic Fracture (Post-operative):
    • Incidence: 0.5-2% annually, increasing with time.
    • Classification: Vancouver classification (A, B1, B2, B3, C) guides management.
    • Management: Dependent on fracture location, stability of components, and bone quality. May involve open reduction internal fixation (ORIF) with wires/plates, or revision arthroplasty (stem revision, total revision).
  • Aseptic Loosening / Osteolysis:
    • Incidence: Varies significantly with implant type and follow-up duration (e.g., poly wear leads to osteolysis in 10-20% at 10-15 years for older implants).
    • Management: Pain, imaging (radiographs, SPECT-CT) to confirm loosening. Revision arthroplasty with bone grafting for osteolysis.
  • Leg Length Discrepancy (LLD):
    • Incidence: Subjective LLD is more common (up to 20%); objective LLD >1 cm, 1-10%.
    • Management: Pre-operative templating, intraoperative measurements. Post-operatively, heel lifts for minor discrepancies (<1.5 cm). Significant LLD or nerve symptoms may rarely require revision.
  • Heterotopic Ossification (HO):
    • Incidence: Radiographic HO 5-50%; symptomatic HO 1-5%. Higher incidence with specific approaches (e.g., DAA without prophylaxis) or risk factors (e.g., ankylosing spondylitis, prior HO).
    • Management: Prophylaxis with NSAIDs (e.g., indomethacin for 3-6 weeks) or single-dose radiation therapy. Excision for symptomatic HO.
  • Implant Wear/Failure:
    • Incidence: Depends on bearing surface and implant longevity. Polyethylene wear can lead to osteolysis.
    • Management: Revision arthroplasty.

TABLE: Common Complications, Incidence, and Salvage Strategies

Complication Incidence (Approx.) Salvage Strategies
Periprosthetic Infection (PJI) 0.5-2% Debridement & Implant Retention (DAIR), One-stage Revision, Two-stage Revision, Resection Arthroplasty, Amputation (rare)
Dislocation 1-5% Closed Reduction, Hip Brace, Component Reorientation, Exchange of Liner/Head, Dual Mobility Components, Constrained Liner, Revision Arthroplasty
Periprosthetic Fracture 0.5-5% (post-op) ORIF (plates, wires), Revision to Longer/Stable Stem, Total Revision Arthroplasty
Aseptic Loosening Varies with follow-up (e.g., 10-20% at 15 yrs) Component Exchange, Revision Arthroplasty (Acetabular, Femoral, or Both)
Leg Length Discrepancy 1-10% (>1cm) Shoe Lift, Patient Education; Rare: Revision Arthroplasty
Nerve Injury (Sciatic, Femoral) 0.1-1% Observation (most resolve), Neurolysis, Physical Therapy
Vascular Injury <0.1% Direct Repair, Bypass Graft
Heterotopic Ossification 1-5% (symptomatic) NSAID/Radiation Prophylaxis; Excision of Mature HO
Thromboembolic Disease DVT: 0.5-5%, PE: 0.1-1% Anticoagulation (LMWH, DOACs), IVC Filter (rare)

Post-Operative Rehabilitation Protocols

Post-operative rehabilitation is crucial for optimizing functional recovery, minimizing complications, and ensuring patient satisfaction after THA. Protocols are increasingly geared towards early mobilization and patient-specific goals, often incorporated into enhanced recovery after surgery (ERAS) pathways.

Immediate Post-Operative Phase (Day 0-3 / Hospital Stay)

  • Pain Management: Multimodal analgesia (oral opioids, NSAIDs/acetaminophen, nerve blocks, regional anesthesia) to minimize pain and facilitate early mobilization.
  • DVT Prophylaxis: Continuation of mechanical and pharmacological prophylaxis.
  • Early Mobilization:
    • Day 0 (Surgery Day): Out of bed to chair, ambulation with assistance (walker) as tolerated, often partial weight-bearing (PWB) or weight-bearing as tolerated (WBAT) depending on surgeon preference and fixation type.
    • Day 1-3: Progressive increase in ambulation distance and duration. Stair training.
  • Hip Precautions (Approach-Specific):
    • Posterior Approach: Avoid hip flexion >90 degrees, internal rotation, and adduction past midline to prevent posterior dislocation. Use of an abduction pillow when lying supine.
    • Anterolateral/Direct Anterior Approach: Typically fewer or no formal precautions, but some surgeons still advise avoiding hyperextension and external rotation in the early phase.
  • Patient Education: Instruction on transfer techniques, use of assistive devices, hip precautions, wound care, and DVT symptoms.
  • Discharge Planning: Assessment for discharge to home with outpatient PT or to a skilled nursing facility/inpatient rehab for those requiring higher levels of care.

Early Rehabilitation Phase (Weeks 1-6)

  • Weight-Bearing: Progress to full weight-bearing (FWB) as tolerated, typically by 2-4 weeks, or earlier based on stability and fixation. Continue with an assistive device (cane or crutches) until stable unassisted gait is achieved.
  • Range of Motion (ROM): Gentle active and active-assisted ROM exercises, respecting hip precautions. Focus on regaining functional flexion and extension.
  • Strengthening:
    • Isometrics: Gluteal sets, quad sets.
    • Theraband Exercises: Gentle hip abduction, adduction, flexion, extension.
    • Specific Muscle Groups: Focus on hip abductors (gluteus medius/minimus), extensors (gluteus maximus), and quadriceps.
  • Gait Training: Focus on normal heel-strike to toe-off pattern, improving stride length, and minimizing compensatory patterns.
  • Activities of Daily Living (ADLs): Training for dressing, bathing, and safe transfers.

Intermediate Rehabilitation Phase (Weeks 6-12)

  • Progressive Strengthening: Increase resistance for hip and core musculature. Incorporate closed-chain exercises (e.g., mini-squats, lunges).
  • Balance Training: Single-leg stance, tandem walking, unstable surfaces.
  • Advanced Gait Mechanics: Refine gait pattern, progress to outdoor walking, address any persistent limp.
  • Functional Activities: Work on endurance, step-ups, negotiating uneven terrain.
  • Return to Light Activities: Gradual reintroduction to low-impact recreational activities (e.g., swimming, cycling).

Late Rehabilitation Phase (Months 3+)

  • Return to Activity: Progression to low-impact sports (e.g., golf, hiking) as tolerated. High-impact activities (e.g., running, jumping sports) are generally discouraged due to increased wear and risk of loosening/fracture.
  • Maintenance Program: Long-term home exercise program focusing on strength, flexibility, and endurance.
  • Long-Term Follow-up: Regular clinical and radiographic follow-up to monitor implant integrity and detect complications.

Summary of Key Literature / Guidelines

The evidence base for THA is extensive and continually evolving, guiding best practices and improving patient care. Several key areas have been informed by high-quality research and clinical practice guidelines.

AAOS Clinical Practice Guidelines (CPGs)

The American Academy of Orthopaedic Surgeons (AAOS) develops evidence-based CPGs for various orthopedic conditions, including THA. Key recommendations pertain to:

  • DVT Prophylaxis: Guidelines recommend shared decision-making regarding pharmacological prophylaxis, noting the efficacy of aspirin, LMWH, and DOACs, weighing risks against benefits. Mechanical prophylaxis is consistently recommended.
  • Surgical Site Infection Prevention: Recommendations include appropriate pre-operative antibiotic timing and selection, use of antiseptic showering, and intraoperative glycemic control.
  • Pain Management: Emphasizes multimodal analgesia protocols to reduce opioid consumption and improve recovery.
  • Implant Selection: While not dictating specific implant types, guidelines review the evidence for various bearing surfaces and fixation methods regarding wear, osteolysis, and longevity.

Evidence-Based Recommendations & Landmark Studies

  1. Bearing Surfaces:
    • Metal-on-Polyethylene (MoP): Historically the most common. Concerns about polyethylene wear-particle induced osteolysis led to development of highly cross-linked polyethylene (HXLPE), which has demonstrated significantly reduced wear rates and improved long-term survivorship compared to conventional polyethylene.
    • Ceramic-on-Ceramic (CoC): Offers very low wear rates and excellent longevity, making it attractive for younger, more active patients. Risk of ceramic fracture and "squeaking" are rare but known complications.
    • Ceramic-on-Polyethylene (CoP): Combines the benefits of ceramic heads (hardness, low friction) with HXLPE liners, offering good wear properties.
    • Metal-on-Metal (MoM): Largely abandoned due to high failure rates, pseudotumor formation, and systemic metallosis concerns.
  2. Fixation Methods (Cemented vs. Uncemented):
    • Cemented Fixation: Remains a viable option, particularly for older patients with poor bone quality (e.g., osteoporosis), offering immediate stability and reliable long-term results with modern cementing techniques (e.g., vacuum mixing, pressurization).
    • Uncemented Fixation: Preferred for younger, active patients with good bone stock, relying on biological ingrowth for long-term stability. Porous coatings (e.g., hydroxyapatite) enhance bone ingrowth. Registry data generally show comparable survivorship between cemented and uncemented fixation in appropriate patient populations.
  3. Surgical Approaches:
    • No single approach has definitively demonstrated superior long-term clinical outcomes or implant survivorship across all patient groups.
    • Direct Anterior Approach (DAA): Gained popularity for potential muscle-sparing benefits, often associated with faster early recovery and fewer hip precautions. However, DAA has a higher learning curve and can be associated with increased rates of lateral femoral cutaneous nerve (LFCN) injury and intraoperative fracture, particularly early in a surgeon's experience.
    • Posterior Approach: Provides excellent exposure and is familiar to many surgeons. Historically associated with a higher dislocation rate if the capsule and short external rotators are not repaired.
    • Anterolateral Approach: Offers good stability but can result in injury to the abductor muscles, potentially leading to a Trendelenburg gait.
  4. Periprosthetic Joint Infection (PJI) Management:
    • The Musculoskeletal Infection Society (MSIS) criteria are widely accepted for diagnosing PJI.
    • Treatment algorithms are stratified by acuity:
      • Acute PJI (<3-6 weeks from surgery): Debridement, antibiotics, and implant retention (DAIR) is a viable option for stable implants.
      • Chronic PJI (>3-6 weeks): Typically requires one-stage or two-stage revision arthroplasty, with the two-stage approach (excision arthroplasty, antibiotic spacer, then reimplantation) being the gold standard for many, especially if resistant organisms are involved.
  5. Enhanced Recovery After Surgery (ERAS) Protocols:
    • Multimodal pathways integrating pre-operative education, nutritional optimization, multimodal pain management, early mobilization, and reduced opioid use have shown to decrease hospital length of stay, reduce complications, and improve patient satisfaction without compromising outcomes.

Registries (e.g., National Joint Registry for England, Wales and Northern Ireland, Australian Orthopaedic Association National Joint Replacement Registry) provide invaluable large-scale data on implant performance, complication rates, and long-term survivorship, continually informing clinical practice. The evolution of THA continues with advancements in robotics, navigation, and patient-specific instrumentation, further refining precision and potentially enhancing outcomes.


You Might Also Like

Dr. Mohammed Hutaif
Medically Verified Content by
Prof. Dr. Mohammed Hutaif
Consultant Orthopedic & Spine Surgeon
Chapter Index